InterAx Biotech Revenue

Biotechnology Research • Schlieren, Zurich, Switzerland • 11-20 Employees

InterAx Biotech revenue & valuation

Annual revenue	$7,000,000
Revenue per employee	$500,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$22,400,000
Total funding	$2,700,000

Key Contacts at InterAx Biotech

Luca Zenone

Co-Founder, Cfo & Coo

Aurélien Rizk

Co-Founder & Cso

Andrew Roberts

Chief Executive Officer

Christopher Prior

Chief Executive Officer

Company overview

Headquarters	Zürcherstrasse 39d, Schlieren, Zurich 8952, CH
Phone number	+41563105754
Website	interaxbiotech.com
NAICS	541714
SIC	873
Keywords	Drug Discovery, Pharmacology, AI, Machine Learning, Systems Biology, Gpcr
Founded	2016
Employees	11-20
Socials

InterAx Biotech Email Formats

InterAx Biotech uses 2 email formats. The most common is {last name} (e.g., doe@interaxbiotech.com), used 92.3% of the time.

Format	Example	Percentage
{last name}	doe@interaxbiotech.com	92.3%
{first initial}.{last name}	j.doe@interaxbiotech.com	7.7%

About InterAx Biotech

The company, a spin-out of ETH Zurich and the Paul Scherrer Institute, Switzerland, uses high throughput biochemical screening of compounds integrated into an artificial intelligence and cell pathways mathematical modeling process. This platform unlocks previously intractable targets, shortens timelines for drug discovery from years to months and reduces risks. The company focuses on the generation and optimization of drugs which trigger a specific and well characterized effect on signaling pathways, thus leading to higher therapeutic efficacy and reduced risk of toxicity. The company is specialized in GPCR drug discovery and covers hit-generation, hit- to-lead and lead optimization for all targets including orphan GPCRs. InterAx AG has a highly experienced and dedicated team of scientists specialized in AI, mathematical models of signaling pathways, cellular pharmacology and computational chemistry.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

C-Suite

Entry

Partner

Employees by Department

InterAx Biotech has 8 employees across 6 departments.

Departments

Number of employees

Funding Data

Explore InterAx Biotech's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2019-10-25	9	$2,700,000

Funding Insights

$2,700,000

Total funding amount

$2,700,000

Most recent funding amount

Number of funding rounds

InterAx Biotech Tech Stack

Discover the technologies and tools that power InterAx Biotech's digital infrastructure, from frameworks to analytics platforms.

Crocoblock JetElements

WordPress plugins

Apache HTTP Server

Web servers

Elementor

Page builders

GeneratePress

WordPress themes

PHP

Programming languages

Open Graph

Miscellaneous

WP Rocket

Caching

OVHcloud

Hosting

WordPress

Blogs

WPMU DEV Smush

WordPress plugins

RankMath SEO

SEO

Swiper

JavaScript libraries

Frequently asked questions

InterAx Biotech is located in Schlieren, Zurich, CH.

You can reach InterAx Biotech at +41563105754.

InterAx Biotech generates an estimated annual revenue of $7,000,000. This revenue figure reflects the company's market position and business performance in its industry.

InterAx Biotech has an estimated valuation of $22,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

InterAx Biotech was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

InterAx Biotech has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

InterAx Biotech has raised a total of $2,700,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at InterAx Biotech

Luca Zenone

Co-Founder, Cfo & Coo

Aurélien Rizk

Co-Founder & Cso

Andrew Roberts

Chief Executive Officer

Christopher Prior

Chief Executive Officer

4.8